A novel microencapsulated peptide vaccine against hepatitis B.

Abstract

A 48 amino acid synthetic peptide (S121/48) representing residues 121-167 of the major envelope protein of hepatitis B virus (HBsAg) was successfully encapsulated into polylactide co-glycolide microspheres. A single immunization of the microspheres in BALB/c (H-2d) mice resulted in the production of high-titre anti-HBs antibodies (IgG1-type). The response… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.